Bell´s Palsy After Astra Zenica COVID-19 Vaccination

  • ALBANNA R
N/ACitations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

We present a case of peripheral facial palsy developing after the first dose of AZD1222, Astra Zeneca`s COVID-19 vaccine. A 31- year-old female received her first dose of AZD1222 vaccine against COVID-19. Later the same day, she developed swelling around her neck and head. The next day, she woke up with hanging eyelid, hanging mouth and loss of sensibility on the left side of her face- indications of peripheral facial paralysis. She later on developed hyperesthesia on the upper extremities. Before vaccination, the patient was healthy and had no history of neurological disease. She fully recovered from the paresis after 2-3 days. Five months after she received her first and only dose of the vaccine, she still complains of severe hyperesthesia in her upper extremities. There have been several international case reports of Bell´s palsy after COVID-19- vaccination, but Bell´s palsy is not yet a confirmed adverse effect of any COVID-19 vaccine. The aim of this case report is to raise awareness about Bell´s palsy as a possible adverse effect of Astra Zeneca´s COVID-19 vaccine.

Cite

CITATION STYLE

APA

ALBANNA, R. (2022). Bell´s Palsy After Astra Zenica COVID-19 Vaccination. Journal of Immunology and Clinical Microbiology, 7(4), 88–91. https://doi.org/10.58854/jicm.1089137

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free